Thermo Fisher Scientific (TMO) Income from Continuing Operations (2009 - 2026)

Thermo Fisher Scientific has reported Income from Continuing Operations for 18 years, with the latest figure at 1757000000.0 in Q2 2026.

• Income from Continuing Operations for Q2 2026 came in at 1757000000.0, up 8.66% year-over-year; the trailing twelve-month figure through Jun 2026 was 7040000000.0 (up 7.06% YoY), and the FY2025 annual result was 6761000000.0, up 5.97% from the prior year.
• Income from Continuing Operations climbed to 1757000000.0 in Q2 2026, from 1664000000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 2239000000.0 in Q2 2022 and troughed at 1308000000.0 in Q1 2024.
• A 5-year average of 1650388888.89 and a median of 1628000000.0 in 2024 frame the typical range for Income from Continuing Operations.
• The widest annual swing landed in 2023, when Income from Continuing Operations plunged 41.18%; it then gained 18.8% in 2024.
• A 5-year view of Income from Continuing Operations shows it stood at 1604000000.0 in 2022, then gained by 0.19% to 1607000000.0 in 2023, then gained by 11.45% to 1791000000.0 in 2024, then climbed by 11.67% to 2000000000.0 in 2025, then declined by 12.15% to 1757000000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 1757000000.0 in Q2 2026, 1664000000.0 in Q1 2026, and 2000000000.0 in Q4 2025.